...
机译:回复致编辑的索拉非尼布加肝动脉输液化疗与顺铂与索拉非尼治疗的先进肝细胞癌:随机期II试验',由Fornaro等。
Natl Canc Ctr Hosp East Dept Hepatobiliary &
Pancreat Oncol Kashiwa Chiba Japan;
Natl Canc Ctr Hosp East Dept Hepatobiliary &
Pancreat Oncol Kashiwa Chiba Japan;
Kyoto Univ Dept Biostat Sch Publ Hlth Kyoto Japan;
Kanagawa Canc Ctr Dept Hepatobiliary &
Pancreat Med Oncol Yokohama Kanagawa Japan;
Natl Ctr Global Hlth &
Med Ctr Hosp Dept Gastroenterol Tokyo Japan;
Aichi Canc Ctr Hosp Dept Diagnost &
Intervent Radiol Nagoya Aichi Japan;
Osaka City Univ Hosp Dept Hepatol Osaka Japan;
Kinki Univ Sch Med Dept Gastroenterol &
Hepatol Osaka Japan;
Osaka Natl Hosp Dept Hepatobiliary &
Pancreat Surg Osaka Japan;
Kanazawa Univ Hosp Dept Gastroenterol Kanazawa Ishikawa Japan;
Natl Hosp Org Kyushu Canc Ctr Dept Hepatobiliary Pancreatol Fukuoka Japan;
Saiseikai Utsunomiya Hosp Dept Gastroenterol Utsunomiya Tochigi Japan;
Sapporo Kosei Gen Hosp Dept Gastroenterol Sapporo Hokkaido Japan;
Kyoto Prefectural Univ Med Dept Mol Gastroenterol &
Hepatol Kyoto Japan;
Kyoto Univ Hosp Inst Adv Clin &
Translat Sci Kyoto Japan;
Shikoku Canc Ctr Clin Res Ctr Matsuyama Ehime Japan;
Kyorin Univ Dept Med Oncol Tokyo Japan;
Natl Canc Ctr Dept Hepatobiliary &
Pancreat Oncol Tokyo Japan;
机译:回复致编辑的索拉非尼布加肝动脉输液化疗与顺铂与索拉非尼治疗的先进肝细胞癌:随机期II试验',由Fornaro等。
机译:晚期肝细胞癌(HICS 55)患者的肝动脉灌注化疗后加索拉非尼:一项开放性,非对照,II期临床研究
机译:索拉非尼联合奥沙利铂与索拉非尼联合肝动脉灌注化疗治疗晚期肝细胞癌
机译:Sorafenib之外的肝细胞癌中的分子疗法:III期试验失败的课程和新型靶标
机译:索拉非尼联合肝动脉灌注化疗联合顺铂与索拉非尼治疗晚期肝细胞癌:II期随机试验
机译:随机,序贯肝动脉输注化疗和索拉非尼试验的II次试验单独作为先进肝细胞癌的初始治疗:SCOOP-2试验